David Veitch is Chief Executive Officer for Basilea Pharmaceutica AG.

In his past career he occupied the position of President-European Operations at Savient Pharmaceuticals, Inc. and SVP-European Marketing & Brand Commercialization at Bristol-Myers Squibb Pharmaceuticals Ltd.

He received an undergraduate degree from the University of Bristol.